What is moving in pharmaceuticals today, worldwide and in China. 22 October 2026.
Approvals, deals, supply and regulation.
Alcon acquires Neurotech: The Swiss eye specialist paid $550 million upfront to acquire Neurotech Pharmaceuticals and could make additional payments if certain milestones are met. Alcon gains hold of an FDA-approved ...
Read at endpoints.newsThe FDA has granted approval for Cosette’s Evoxac oral solution to treat dry mouth symptoms in adults diagnosed with Sjögren’s disease.
Read at pharmaceutical-technology.comFDA Approves Hibsago | PharmExec Pharmaceutical Executive
Read at pharmexec.comTrend in China
Finished dosage forms and active ingredients.
ESTEVE CDMO expands its presence in Asia with a major investment and new manufacturing site in China Voice of ASIA
Read at voiceofasean.comEurope’s last penicillin plant faces a bitter fight against China’s cheaper drugs The Economic Times
Read at m.economictimes.comKyrgyzstan to build veterinary drug plant with Chinese partners 24.KG
Read at 24.kgUpdated every morning. Headlines, summaries and images belong to the publishers named; the selection is not a Hanpars opinion. Our own articles are in the Insights archive.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.
